The U.S. Food and Drug Administration has approved a new first-line treatment for people with pleural mesothelioma that can’t be removed with surgery. This…
A new grant program with $75 million in state funding aims to keep Pennsylvania school children safe. According to Pennsylvania Governor Josh Shapiro, the…
The McLean County Museum of History in Bloomington, Illinois recently unveiled a new exhibit focusing on asbestos, corporate deception and the fight for workers’…
Johnson & Johnson is adding $1.1 billion to its proposed talc settlement of $6.475 billion to resolve approximately 62,000 personal injury talc lawsuits. If…
Several schools in the U.S. are dealing with recent asbestos discoveries. Exposure concerns are causing disruptions just as students are back or heading back…
Avon Products Inc. has filed for bankruptcy as it faces 200 lawsuits related to its talc-based products. Plaintiffs claim their cancer diagnoses are the…
More than 75% of plaintiffs have voted to support Johnson & Johnson’s proposed plan to settle roughly 61,000 lawsuits for $6.475 billion, according to…
Your web browser is no longer supported by Microsoft. Update your browser for more security, speed and compatibility.
If you are looking for mesothelioma support, please contact our Patient Advocates at (855) 404-4592
Who Am I Calling?
Calling this number connects you with a Patient Advocate at The Mesothelioma Center, the nation's most trusted mesothelioma resource.
Our Patient Advocates can help guide you or your loved one through the steps to take after a mesothelioma diagnosis. Our team has a combined experience of more than 30 years in assisting cancer patients, and includes a medical doctor, an oncology registered nurse and a U.S. Navy veteran.
Mesothelioma Center - Vital Services for Cancer Patients & Families doesn’t believe in selling customer information. However, as required by the new California Consumer Privacy Act (CCPA), you may record your preference to view or remove your personal information by completing the form below.
